Status:
COMPLETED
A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Axcan Pharma
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-45 years
Phase:
PHASE2
PHASE3
Brief Summary
A 7 day study which involves 2 nutrient drink tests, an ECG, a Scintigraphy scan, and a Sect scan. This study requires the participant to make 4 visits to the GCRC in the Charlton building but no over...
Detailed Description
A screening interview and symptoms assessment by the Bowel Disease Questionnaire (BDQ) and consent will be obtained prior to the studies at the testing facility (General Clinical Research Center, 7th ...
Eligibility Criteria
Inclusion
- Non-pregnant, non-breastfeeding females;
- 18- 45 years old
- Body mass index between 20 and 32 kg/m2
- No alarm indicators on clinical assessment (weight loss of more than 7kg, bleeding, recent recurrent vomiting, progressive dysphagia).
- No history suggestive of small bowel obstruction
Exclusion
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00308399
Start Date
November 1 2005
End Date
June 1 2007
Last Update
March 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905